Td Asset Management Inc Deciphera Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$14.26 - $22.1 $31,372 - $48,620	-2,200 Reduced 5.07%	41,200 $636,000
Q4 2022 Feb 06, 2023	SELL	$14.85 - $19.04 $78,705 - $100,912	-5,300 Reduced 10.88%	43,400 $711,000
Q3 2022 Nov 07, 2022	BUY	$12.38 - $20.23 $476,630 - $778,855	38,500 Added 377.45%	48,700 $858,000
Q2 2022 Aug 04, 2022	BUY	$9.11 - $13.98 $92,922 - $142,596	10,200 New	10,200 $134,000
Q4 2021 Feb 10, 2022	SELL	$7.7 - $37.13 $113,243 - $546,070	-14,707 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$32.73 - $47.95 $336,300 - $492,686	-10,275 Reduced 41.13%	14,707 $448,000
Q1 2021 May 14, 2021	BUY	$40.39 - $56.73 $123,714 - $173,763	3,063 Added 13.97%	24,982 $1.12 Million
Q3 2020 Nov 10, 2020	SELL	$43.8 - $58.16 $455,519 - $604,864	-10,400 Reduced 32.18%	21,919 $1.12 Million
Q2 2020 Aug 13, 2020	BUY	$37.05 - $65.03 $96,329 - $169,078	2,600 Added 8.75%	32,319 $1.93 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $77,349 - $159,620	-2,300 Reduced 7.18%	29,719 $1.22 Million
Q4 2019 Feb 11, 2020	BUY	$31.7 - $69.93 $672,040 - $1.48 Million	21,200 Added 195.95%	32,019 $1.99 Million
Q3 2019 Nov 07, 2019	BUY	$19.95 - $38.85 $215,839 - $420,318	10,819 New	10,819 $367,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.